Adagene Inc. ADAG

Set alert

Price alert · ADAG

All alert types
2.39 USD +0.10 +4.37%

As of Nov 3, 2:26 PM ET

Bid
2.38 × 2
Ask
2.40 × 3
2.26 Day range 2.54
1.30 52-week range 4.85
YTD
+26.46%
1 year
+33.52%
Open
2.26
Prev close
2.29
Mkt cap
160.47M
Vol
76.29K
Avg vol
281.63K
EPS
-0.37
P/E
0.00
Div yield
0.00%
More statistics
Low
2.26
High
2.54
Forward P/E
-2.81
Beta
0.58
Short ratio
0.66
Inst. own
25.20%
Dividend
0.00
Ex-div date
Earnings
Apr 2, 2024
50-d avg
2.44
200-d avg
2.59
1y target
8.03

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ADAG has not been loaded yet. Try again in a moment.

Analyst view

Price target (mean) 8.03 +235.9% upside
Target (low)
3.50
Target (mean)
8.03
Target (high)
18.81
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy1
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ADAG analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current year-0.58-0.72 – -0.44-0.21-176.2%12.33M-31.9%2
Next year-0.775-1.04 – -0.51-0.58-33.6%12.67M+2.7%2

Upgrades and downgrades

The latest rating changes

ADAG analyst upgrades and downgrades
DateFirmActionFromTo
Sep 18, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 28, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 4, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 1, 2023HC Wainwright & Co.ReiteratedBuyBuy
Apr 21, 2023HC Wainwright & Co.Reiterated—Buy
Mar 29, 2023HC Wainwright & Co.Reiterated—Buy
Mar 21, 2023HC Wainwright & Co.Reiterated—Buy
Jan 24, 2023Morgan StanleyMaintained—Overweight
Dec 7, 2022HC Wainwright & Co.Initiated—Buy
Sep 9, 2022Morgan StanleyMaintained—Overweight
Feb 1, 2022Morgan StanleyMaintained—Overweight
Jan 6, 2022Morgan StanleyMaintained—Overweight
Jul 16, 2021Morgan StanleyMaintained—Overweight
Jun 25, 2021China RenaissanceInitiated—Buy
Mar 8, 2021JefferiesInitiated—Buy
Mar 8, 2021Morgan StanleyInitiated—Overweight